Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15959931rdf:typepubmed:Citationlld:pubmed
pubmed-article:15959931lifeskim:mentionsumls-concept:C0002062lld:lifeskim
pubmed-article:15959931lifeskim:mentionsumls-concept:C0001044lld:lifeskim
pubmed-article:15959931lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15959931lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15959931lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:15959931lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:15959931pubmed:issue4lld:pubmed
pubmed-article:15959931pubmed:dateCreated2005-6-15lld:pubmed
pubmed-article:15959931pubmed:abstractTextAcetylcholinesterase plays a crucial role in the metabolism of neurotransmitter, acetylcholine. Inhibition of Torpedo californica acetylcholinesterase by triterpenoidal alkaloids buxamine-B (1) and buxamine-C (2) has been studied by enzyme kinetics and molecular docking experiments. Buxamine-C (2) has been found to be 20-fold potent than buxamine-B (1) (Ki = 5.5 and 110 microM, respectively). The ligand docking experiments predicted that the cyclopentanophenanthrene skeleton of both inhibitors properly fits into the aromatic gorge of the enzyme. The C-3 and C-20 amino groups of both alkaloids mimic the well-known bis-quaternary ammonium inhibitors such as decamethonium and interact with Trp84 and Trp279 residues of the enzyme, respectively. The C-3 amino group in buxamine-C (2) appears to be better positioned at the bottom of the aromatic gorge and thus seems to be crucial for the inhibitory activity of such inhibitors.lld:pubmed
pubmed-article:15959931pubmed:languageenglld:pubmed
pubmed-article:15959931pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15959931pubmed:citationSubsetIMlld:pubmed
pubmed-article:15959931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15959931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15959931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15959931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15959931pubmed:statusMEDLINElld:pubmed
pubmed-article:15959931pubmed:monthJunlld:pubmed
pubmed-article:15959931pubmed:issn0006-291Xlld:pubmed
pubmed-article:15959931pubmed:authorpubmed-author:Atta-ur-Rahma...lld:pubmed
pubmed-article:15959931pubmed:authorpubmed-author:KhalidAsaadAlld:pubmed
pubmed-article:15959931pubmed:authorpubmed-author:ChoudharyM...lld:pubmed
pubmed-article:15959931pubmed:authorpubmed-author:AzimM...lld:pubmed
pubmed-article:15959931pubmed:authorpubmed-author:ParveenShehna...lld:pubmed
pubmed-article:15959931pubmed:issnTypePrintlld:pubmed
pubmed-article:15959931pubmed:day17lld:pubmed
pubmed-article:15959931pubmed:volume331lld:pubmed
pubmed-article:15959931pubmed:ownerNLMlld:pubmed
pubmed-article:15959931pubmed:authorsCompleteYlld:pubmed
pubmed-article:15959931pubmed:pagination1528-32lld:pubmed
pubmed-article:15959931pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15959931pubmed:meshHeadingpubmed-meshheading:15959931...lld:pubmed
pubmed-article:15959931pubmed:meshHeadingpubmed-meshheading:15959931...lld:pubmed
pubmed-article:15959931pubmed:meshHeadingpubmed-meshheading:15959931...lld:pubmed
pubmed-article:15959931pubmed:meshHeadingpubmed-meshheading:15959931...lld:pubmed
pubmed-article:15959931pubmed:meshHeadingpubmed-meshheading:15959931...lld:pubmed
pubmed-article:15959931pubmed:meshHeadingpubmed-meshheading:15959931...lld:pubmed
pubmed-article:15959931pubmed:year2005lld:pubmed
pubmed-article:15959931pubmed:articleTitleStructural basis of acetylcholinesterase inhibition by triterpenoidal alkaloids.lld:pubmed
pubmed-article:15959931pubmed:affiliationDr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical Sciences, University of Karachi, Pakistan.lld:pubmed
pubmed-article:15959931pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15959931pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed